Sorcin is upregulated in many cisplatin-resistant cancers and tumor cell lines, such as leukemia, nasopharyngeal carcinoma, and lung cancer, while sorcin silencing increases cisplatin cytotoxicity and glutathione depletion [54,69,71]. Here, SRI is linked to cancer.